© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

SRI

Top section

Top section

NatWest plays for duration with long-dated holding company senior

◆ Two steps to terms debated ◆ Priced flat to fair value or even with negative concession ◆ Investors split on long-dated holdco supply
When loans' LTVs hit 80%, Bitcoin stakes are liquidated in seconds

Erlandsson to leave Anthropocene Fixed Income Institute, return to AP4

Founder of climate investing think tank wants to apply ideas as bond investor

Missing mandates need not be so miserable

No one wins playing the blame game
When loans' LTVs hit 80%, Bitcoin stakes are liquidated in seconds
Sub-sections
  • Hope of a Covid-19 vaccine ignited risk appetite for equity and corporate credit this week, as companies in struggling sectors enjoyed soaring share prices and printed bonds through fair value, write Mike Turner, Sam Kerr and Aidan Gregory.
  • Financial institutions jumped into action this week, as positive news on the development of a Covid-19 vaccine led to superlative funding conditions in the euro market.
  • The Central American Bank for Economic Integration (Cabei) said it became the first multilateral lender to sell a Covid-19 “vaccine bond” after raising $50m of five-year money to support immunisation initiatives when Covid-19 vaccine becomes available.